MedTrace Logo

Effect Narrow-Band UVB Radiations

NCT05647187 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-12-12

No results posted yet for this study

Summary

Narrow-band UVR affects Interleukin 17 which has a major role in the pathogenesis of psoriasis Vulgaris. the aim of this study to evaluate the serum levels of Interleukin 17 in psoriatic patients and compare with the levels in healthy controls \& evaluate the effect of narrow-band ultraviolet B (NB-UVB) on the serum of Interleukin 17 and the treatment of psoriasis Vulgaris.

Conditions

  • Psoriasis Vulgaris
  • UVB Phototherapy Burn

Interventions

DIAGNOSTIC_TEST

Serum Interleukin 17 levels

Serum Interleukin 17 levels will be measured pre and post treatment by NB-UVB by performing an enzyme-linked immune sorbent assay (ELISA)

RADIATION

NB-UVB

patients will be exposed to narrow band UVB twice weekly for three months

Sponsors & Collaborators

  • South Valley University

    lead OTHER

Principal Investigators

  • Hassan M Ibrahim, professor · South Valley University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-07-01
Completion
2021-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05647187 on ClinicalTrials.gov